S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   267.08 (-1.20%)
AAPL   106.99 (-3.04%)
MSFT   200.28 (-1.30%)
FB   252.74 (-0.82%)
GOOGL   1,451.90 (-2.36%)
AMZN   2,955.00 (-1.79%)
NVDA   487.90 (-2.13%)
TSLA   443.86 (+4.82%)
BABA   272.58 (-1.14%)
CGC   16.35 (-0.30%)
GE   6.87 (-2.55%)
MU   50.74 (-0.47%)
AMD   74.94 (-2.10%)
T   28.96 (-0.38%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   470.00 (-0.04%)
DIS   128.99 (-0.94%)
BAC   25.24 (-0.43%)
BA   161.42 (-3.65%)
S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   267.08 (-1.20%)
AAPL   106.99 (-3.04%)
MSFT   200.28 (-1.30%)
FB   252.74 (-0.82%)
GOOGL   1,451.90 (-2.36%)
AMZN   2,955.00 (-1.79%)
NVDA   487.90 (-2.13%)
TSLA   443.86 (+4.82%)
BABA   272.58 (-1.14%)
CGC   16.35 (-0.30%)
GE   6.87 (-2.55%)
MU   50.74 (-0.47%)
AMD   74.94 (-2.10%)
T   28.96 (-0.38%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   470.00 (-0.04%)
DIS   128.99 (-0.94%)
BAC   25.24 (-0.43%)
BA   161.42 (-3.65%)
S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   267.08 (-1.20%)
AAPL   106.99 (-3.04%)
MSFT   200.28 (-1.30%)
FB   252.74 (-0.82%)
GOOGL   1,451.90 (-2.36%)
AMZN   2,955.00 (-1.79%)
NVDA   487.90 (-2.13%)
TSLA   443.86 (+4.82%)
BABA   272.58 (-1.14%)
CGC   16.35 (-0.30%)
GE   6.87 (-2.55%)
MU   50.74 (-0.47%)
AMD   74.94 (-2.10%)
T   28.96 (-0.38%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   470.00 (-0.04%)
DIS   128.99 (-0.94%)
BAC   25.24 (-0.43%)
BA   161.42 (-3.65%)
S&P 500   3,319.47 (-1.12%)
DOW   27,657.42 (-0.88%)
QQQ   267.08 (-1.20%)
AAPL   106.99 (-3.04%)
MSFT   200.28 (-1.30%)
FB   252.74 (-0.82%)
GOOGL   1,451.90 (-2.36%)
AMZN   2,955.00 (-1.79%)
NVDA   487.90 (-2.13%)
TSLA   443.86 (+4.82%)
BABA   272.58 (-1.14%)
CGC   16.35 (-0.30%)
GE   6.87 (-2.55%)
MU   50.74 (-0.47%)
AMD   74.94 (-2.10%)
T   28.96 (-0.38%)
F   7.23 (-0.69%)
ACB   6.53 (-5.22%)
GILD   65.05 (+0.02%)
NFLX   470.00 (-0.04%)
DIS   128.99 (-0.94%)
BAC   25.24 (-0.43%)
BA   161.42 (-3.65%)
Log in
NASDAQ:CNMD

CONMED Stock Forecast, Price & News

$77.66
-5.24 (-6.32 %)
(As of 09/18/2020 04:00 PM ET)
Add
Compare
Today's Range
$77.35
Now: $77.66
$83.63
50-Day Range
$81.83
MA: $85.27
$89.20
52-Week Range
$37.66
Now: $77.66
$116.81
Volume24,742 shs
Average Volume379,906 shs
Market Capitalization$2.22 billion
P/E Ratio81.75
Dividend Yield0.95%
Beta0.56
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors; and VCARE uterine manipulator for enhancing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.
Read More
CONMED logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.65 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:CNMD
CUSIP20741010
Phone315-797-8375

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$955.10 million
Cash Flow$3.39 per share
Book Value$23.54 per share

Profitability

Net Income$28.62 million

Miscellaneous

Employees3,100
Market Cap$2.22 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$77.66
-5.24 (-6.32 %)
(As of 09/18/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CNMD News and Ratings via Email

Sign-up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CONMED (NASDAQ:CNMD) Frequently Asked Questions

How has CONMED's stock been impacted by COVID-19 (Coronavirus)?

CONMED's stock was trading at $78.77 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CNMD stock has decreased by 0.7% and is now trading at $78.18.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of CONMED?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CONMED
.

When is CONMED's next earnings date?

CONMED is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for CONMED
.

How were CONMED's earnings last quarter?

CONMED Co. (NASDAQ:CNMD) released its quarterly earnings results on Wednesday, July, 29th. The medical technology company reported ($0.07) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.95) by $0.88. The medical technology company earned $157.80 million during the quarter, compared to analysts' expectations of $126.59 million. CONMED had a return on equity of 11.18% and a net margin of 3.00%. CONMED's revenue for the quarter was down 33.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.56 EPS.
View CONMED's earnings history
.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED declared a quarterly dividend on Friday, August 14th. Stockholders of record on Tuesday, September 15th will be given a dividend of $0.20 per share on Monday, October 5th. This represents a $0.80 annualized dividend and a yield of 1.02%. The ex-dividend date is Monday, September 14th.
View CONMED's dividend history
.

What price target have analysts set for CNMD?

6 brokers have issued 12 month price targets for CONMED's shares. Their forecasts range from $76.00 to $115.00. On average, they expect CONMED's share price to reach $98.00 in the next twelve months. This suggests a possible upside of 25.4% from the stock's current price.
View analysts' price targets for CONMED
.

Who are some of CONMED's key competitors?

What other stocks do shareholders of CONMED own?

Who are CONMED's key executives?

CONMED's management team includes the following people:
  • Mr. Curt R. Hartman, CEO, Pres & Director (Age 55)
  • Mr. Todd W. Garner, Exec. VP & CFO (Age 50)
  • Mr. Patrick J. Beyer, Pres of CONMED International (Age 53)
  • Mr. Stanley W. Peters III, VP & GM of U.S. Advanced Surgical (Age 44)
  • Mr. Nathan Folkert, VP & GM of U.S. Orthopedics (Age 44)

What is CONMED's stock symbol?

CONMED trades on the NASDAQ under the ticker symbol "CNMD."

Who are CONMED's major shareholders?

CONMED's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.65%), Point72 Asset Management L.P. (4.00%), Principal Financial Group Inc. (3.59%), Principal Financial Group Inc. (3.59%), Macquarie Group Ltd. (2.59%) and Goldman Sachs Group Inc. (1.99%). Company insiders that own CONMED stock include Brian Concannon, Daniel Jonas, Dirk Kuyper, Heather L Cohen, John Jed Kennedy, John L Workman, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III, Terence M Berge and Wilfredo Ruiz-Caban.
View institutional ownership trends for CONMED
.

Which major investors are selling CONMED stock?

CNMD stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Victory Capital Management Inc., Prudential Financial Inc., Sei Investments Co., SG Americas Securities LLC, Federated Hermes Inc., Engineers Gate Manager LP, and Marshall Wace LLP. Company insiders that have sold CONMED company stock in the last year include Brian Concannon, Daniel Jonas, John Jed Kennedy, Peter K Shagory, Stanley W Peters III, and Wilfredo Ruiz-Caban.
View insider buying and selling activity for CONMED
.

Which major investors are buying CONMED stock?

CNMD stock was acquired by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Ceredex Value Advisors LLC, Balyasny Asset Management LLC, BNP PARIBAS ASSET MANAGEMENT Holding S.A., Assenagon Asset Management S.A., AMI Asset Management Corp, Principal Financial Group Inc., and Principal Financial Group Inc.. Company insiders that have bought CONMED stock in the last two years include Heather L Cohen, and John L Workman.
View insider buying and selling activity for CONMED
.

How do I buy shares of CONMED?

Shares of CNMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CONMED's stock price today?

One share of CNMD stock can currently be purchased for approximately $78.18.

How big of a company is CONMED?

CONMED has a market capitalization of $2.23 billion and generates $955.10 million in revenue each year. The medical technology company earns $28.62 million in net income (profit) each year or $2.64 on an earnings per share basis. CONMED employs 3,100 workers across the globe.

What is CONMED's official website?

The official website for CONMED is www.conmed.com.

How can I contact CONMED?

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The medical technology company can be reached via phone at 315-797-8375.

This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.